Zydus Wellness Ltd
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
- Market Cap ₹ 12,813 Cr.
- Current Price ₹ 2,014
- High / Low ₹ 2,484 / 1,493
- Stock P/E 427
- Book Value ₹ 634
- Dividend Yield 0.30 %
- ROCE 1.08 %
- ROE 0.74 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 22.4% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 89.0%
- Company's working capital requirements have reduced from 98.8 days to 14.1 days
Cons
- Stock is trading at 3.18 times its book value
- Company has a low return on equity of 1.07% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
203 | 219 | 200 | 225 | 264 | 255 | 153 | 114 | 216 | 251 | 245 | 293 | |
122 | 126 | 122 | 137 | 152 | 182 | 174 | 164 | 222 | 213 | 212 | 256 | |
Operating Profit | 81 | 93 | 78 | 88 | 112 | 72 | -21 | -50 | -5 | 38 | 33 | 37 |
OPM % | 40% | 42% | 39% | 39% | 42% | 28% | -14% | -44% | -2% | 15% | 13% | 13% |
12 | 20 | 30 | 25 | 28 | 57 | 109 | -60 | 15 | 13 | 18 | 12 | |
Interest | 0 | 0 | 0 | 0 | 2 | 30 | 140 | 75 | 2 | 1 | 3 | 4 |
Depreciation | 2 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
Profit before tax | 91 | 109 | 104 | 109 | 134 | 97 | -55 | -188 | 5 | 47 | 45 | 41 |
Tax % | -6% | -0% | 1% | -1% | 0% | 1% | -26% | -3% | -143% | -41% | 25% | 25% |
96 | 109 | 103 | 109 | 134 | 96 | -41 | -182 | 13 | 66 | 34 | 31 | |
EPS in Rs | 24.69 | 27.88 | 26.43 | 27.98 | 34.24 | 16.70 | -7.06 | -28.62 | 2.00 | 10.43 | 5.30 | 4.81 |
Dividend Payout % | 24% | 22% | 25% | 23% | 23% | 30% | -71% | -17% | 251% | 48% | 94% | 125% |
Compounded Sales Growth | |
---|---|
10 Years: | 3% |
5 Years: | 14% |
3 Years: | 11% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | -12% |
5 Years: | 22% |
3 Years: | 33% |
TTM: | -9% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 8% |
3 Years: | 9% |
1 Year: | -7% |
Return on Equity | |
---|---|
10 Years: | 2% |
5 Years: | 0% |
3 Years: | 1% |
Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 39 | 39 | 39 | 39 | 39 | 58 | 58 | 64 | 64 | 64 | 64 | 64 |
Reserves | 286 | 367 | 440 | 518 | 652 | 3,268 | 3,157 | 3,956 | 3,937 | 3,971 | 3,972 | 3,971 |
0 | 0 | 0 | 25 | 25 | 1,566 | 1,516 | 50 | 46 | 0 | 51 | 130 | |
48 | 45 | 19 | 23 | 23 | 62 | 72 | 47 | 44 | 32 | 29 | 49 | |
Total Liabilities | 373 | 451 | 498 | 605 | 739 | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,214 |
53 | 44 | 43 | 40 | 38 | 37 | 43 | 44 | 45 | 54 | 54 | 57 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 0 | 4 | 8 |
Investments | 146 | 100 | 209 | 254 | 294 | 3,690 | 3,528 | 3,671 | 3,683 | 3,698 | 3,676 | 4,061 |
175 | 306 | 245 | 310 | 407 | 1,226 | 1,231 | 400 | 360 | 314 | 382 | 88 | |
Total Assets | 373 | 451 | 498 | 605 | 739 | 4,954 | 4,803 | 4,116 | 4,090 | 4,067 | 4,116 | 4,214 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
88 | 89 | 79 | 88 | 113 | 86 | -20 | -52 | -16 | 37 | 26 | 46 | |
-42 | 70 | -19 | -78 | -109 | -4,131 | 267 | 816 | 39 | 1 | -47 | -96 | |
-27 | -27 | -58 | -6 | -2 | 4,049 | -260 | -710 | -38 | -79 | 15 | 43 | |
Net Cash Flow | 18 | 131 | 1 | 4 | 2 | 4 | -13 | 54 | -15 | -42 | -6 | -7 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 1 | 0 | 1 | 1 | 9 | 1 | 5 | 19 | 4 | 12 | 4 |
Inventory Days | 34 | 25 | 23 | 38 | 32 | 24 | 57 | 67 | 22 | 20 | 23 | 22 |
Days Payable | 94 | 58 | 71 | 93 | 84 | 106 | 151 | 158 | 75 | 44 | 45 | 26 |
Cash Conversion Cycle | -60 | -32 | -48 | -55 | -50 | -73 | -93 | -85 | -34 | -20 | -10 | 1 |
Working Capital Days | -71 | -63 | -23 | -20 | -16 | -8 | -26 | 15 | 19 | 144 | 138 | 14 |
ROCE % | 31% | 30% | 23% | 21% | 21% | 4% | 2% | 0% | 0% | 1% | 1% | 1% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
17h - Certificate under Reg. 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended on June 30, 2025
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Newspaper publication for 31st AGM scheduled on July 30, 2025
-
Business Responsibility and Sustainability Reporting (BRSR)
7 Jul - Zydus Wellness files FY 2024-25 Business Responsibility and Sustainability Report detailing ESG initiatives and compliance.
- Notice Of 31St Annual General Meeting Scheduled On July 30, 2025 7 Jul
- Reg. 34 (1) Annual Report. 7 Jul
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Oct 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
May 2021TranscriptPPT
-
Jan 2021TranscriptPPT
-
Oct 2020TranscriptPPT
-
Sep 2020TranscriptNotesPPT
-
Jul 2020TranscriptPPT
-
May 2020TranscriptPPT
-
Jan 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Jul 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Oct 2018TranscriptPPT
-
Jul 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Jan 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016Transcript PPT
-
Jul 2016TranscriptPPT
-
Jun 2016TranscriptNotesPPT
Business Segments:[1]
Zydus Wellness operates primarily in the consumer wellness sector. Its key segments include:
a)Food & Nutrition: Notable brands and products such as Glucon-D, Complan, and Sugar-Free.
b) Personal Care: This segment covers products like Everyuth, Scrubs Peel-off masks, and Nycil Prickly Heat Powder.